These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24427835)

  • 21. N-of-1 trials: an opportunity to tailor treatment in individual patients.
    Madhok V; Fahey T
    Br J Gen Pract; 2005 Mar; 55(512):171-2. PubMed ID: 15808030
    [No Abstract]   [Full Text] [Related]  

  • 22. The prospective, randomized, double-blind clinical trial in orthopaedic surgery.
    Maffulli N
    J Bone Joint Surg Am; 1998 Jun; 80(6):923. PubMed ID: 9655110
    [No Abstract]   [Full Text] [Related]  

  • 23. Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?
    O'Neil WM; Welner SA; Lip GY
    Thromb Haemost; 2013 Mar; 109(3):497-503. PubMed ID: 23348922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open-label surgical trials for Parkinson disease: time for reconsideration.
    Alterman RL; Tagliati M; Olanow CW
    Ann Neurol; 2011 Jul; 70(1):5-8. PubMed ID: 21786295
    [No Abstract]   [Full Text] [Related]  

  • 26. Is the placebo powerless?
    Kupers R
    N Engl J Med; 2001 Oct; 345(17):1278; author reply 1278-9. PubMed ID: 11680457
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 28. Design and implementation of clinical studies in chronic nonhealing wounds.
    Knighton DR; Loss L
    Prog Clin Biol Res; 1991; 365():67-76. PubMed ID: 1862154
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized, double-masked comparison of oxytocin dosage in induction and augmentation of labor.
    Littell RD
    Obstet Gynecol; 2000 Mar; 95(3):472; author reply 472-3. PubMed ID: 10711567
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiemetic study design: desirable objectives, stratifications and analyses.
    Olver IN
    Br J Cancer Suppl; 1992 Dec; 19():S30-3; discussion S33-4. PubMed ID: 1467198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In clinical trials and in the clinic, what is the placebo's effect?
    Wang L
    J Natl Cancer Inst; 2003 Jan; 95(1):6-7. PubMed ID: 12509390
    [No Abstract]   [Full Text] [Related]  

  • 32. Understanding and critiquing quantitative research papers.
    Lee P
    Nurs Times; 2006 Jul 11-17; 102(28):28-30. PubMed ID: 16869219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpreting HIV clinical trials.
    Glesby MJ
    AIDS Clin Care; 1999 Jul; 11(7):58-9. PubMed ID: 11366435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Placebo surgery for clinical studies?].
    Neye H
    Med Monatsschr Pharm; 1999 Oct; 22(10):317-9. PubMed ID: 10540804
    [No Abstract]   [Full Text] [Related]  

  • 35. Regarding "Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study".
    Baxter BT
    J Vasc Surg; 2001 Oct; 34(4):757-8. PubMed ID: 11668336
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conclusion without support - remarks on 'Efficacy and safely of doxyphyllin compared to Theophylline in chronic reversible asthma- a double-blind randomized placebo-controlled multicentre trial' by Goldstein MF, Chervinsky P (published in MedSciMonit, 2002; 8(4):CR297-304.
    Bense L
    Med Sci Monit; 2002 Aug; 8(8):LE27-8. PubMed ID: 12229856
    [No Abstract]   [Full Text] [Related]  

  • 38. Of mice but not men. Problems of the randomized clinical trial.
    Hellman S; Hellman DS
    N Engl J Med; 1991 May; 324(22):1585-9. PubMed ID: 2027362
    [No Abstract]   [Full Text] [Related]  

  • 39. Design of adaptive two-stage double-arm clinical trials for dichotomous variables.
    Jiang Z; Xue F; Li C; Wang L; Cai H; Zhang C; Xia J
    Contemp Clin Trials; 2010 May; 31(3):242-50. PubMed ID: 20172053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.